UBS Group’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,700
Closed -$23K 10430
2022
Q1
$23K Sell
5,700
-17,794
-76% -$71.8K ﹤0.01% 6283
2021
Q4
$83K Buy
23,494
+719
+3% +$2.54K ﹤0.01% 5400
2021
Q3
$83K Sell
22,775
-880
-4% -$3.21K ﹤0.01% 4881
2021
Q2
$103K Sell
23,655
-32,486
-58% -$141K ﹤0.01% 4823
2021
Q1
$230K Sell
56,141
-69,992
-55% -$287K ﹤0.01% 4422
2020
Q4
$503K Buy
126,133
+96,519
+326% +$385K ﹤0.01% 3675
2020
Q3
$80K Sell
29,614
-75,525
-72% -$204K ﹤0.01% 4480
2020
Q2
$290K Sell
105,139
-30,221
-22% -$83.4K ﹤0.01% 3757
2020
Q1
$320K Sell
135,360
-72,840
-35% -$172K ﹤0.01% 3549
2019
Q4
$979K Buy
208,200
+78,376
+60% +$369K ﹤0.01% 3355
2019
Q3
$435K Buy
129,824
+79,344
+157% +$266K ﹤0.01% 3837
2019
Q2
$166K Buy
50,480
+9,024
+22% +$29.7K ﹤0.01% 4219
2019
Q1
$126K Sell
41,456
-38,238
-48% -$116K ﹤0.01% 4143
2018
Q4
$217K Buy
79,694
+38,699
+94% +$105K ﹤0.01% 4060
2018
Q3
$138K Buy
40,995
+20,080
+96% +$67.6K ﹤0.01% 4477
2018
Q2
$54K Buy
20,915
+18,915
+946% +$48.8K ﹤0.01% 5022
2018
Q1
$4K Sell
2,000
-12,986
-87% -$26K ﹤0.01% 6469
2017
Q4
$30K Buy
14,986
+2,228
+17% +$4.46K ﹤0.01% 5280
2017
Q3
$41K Buy
12,758
+4,758
+59% +$15.3K ﹤0.01% 5052
2017
Q2
$26K Buy
8,000
+1,500
+23% +$4.88K ﹤0.01% 5183
2017
Q1
$18K Sell
6,500
-8,055
-55% -$22.3K ﹤0.01% 5309
2016
Q4
$34K Buy
14,555
+12,555
+628% +$29.3K ﹤0.01% 5217
2016
Q3
$3K Sell
2,000
-15,224
-88% -$22.8K ﹤0.01% 6384
2016
Q2
$18K Buy
17,224
+15,224
+761% +$15.9K ﹤0.01% 5512
2016
Q1
$2K Sell
2,000
-9,940
-83% -$9.94K ﹤0.01% 6463
2015
Q4
$14K Sell
11,940
-8,379
-41% -$9.83K ﹤0.01% 5832
2015
Q3
$34K Buy
20,319
+14,619
+256% +$24.5K ﹤0.01% 5017
2015
Q2
$12K Sell
5,700
-5,701
-50% -$12K ﹤0.01% 5878
2015
Q1
$30K Sell
11,401
-11,264
-50% -$29.6K ﹤0.01% 5053
2014
Q4
$59K Buy
+22,665
New +$59K ﹤0.01% 4589